Featured Article
SILVER SPRING, MD (April 13, 2018) – Organizations around the world will join forces on May 5 to raise awareness for pulmonary hypertension (PH). PH is a complex, life-threatening, too-often misdiagnosed progressive illness that affects 25 million adults and children worldwide. On World PH Day, dozens of sister organizations will raise awareness for the need
By Nathan Verlinden, Cardiology Clinical Pharmacy Specialist, Allegheny General Hospital, Pittsburgh Nathan Verlinden received his PharmD from Drake University in Des Moines, Iowa, in 2013. He then completed a post-graduate year 1 (PGY-1) pharmacy practice residency at the University of Toledo Medical Center in Toledo, Ohio, followed by a PGY-2 specialty residency in cardiology at
"If I didn’t have the medication I wouldn’t be around. I would have passed away. And I don’t want to do that because I have great grandchildren and I want to see them grow up." -Edith Edith, a 71-year-old Medicare recipient diagnosed with PH five years ago. When the non-profit charity she had relied
Nadine Al-Naamani, M.D., M.S., University of Pennsylvania, and Andrew Sweatt, M.D., Stanford University, were the research awardees of the 2017 Aldrighetti Research Award for Young Investigators and PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension, respectively. In this two-part series, the 2017 PHA Research Program awardees detail their journey to PH, and their hopes for
by Phyllis Hanlon, Contributing Writer The Centers for Disease Control and Prevention (CDC) reports that about 15.7 million people in the U.S. have been diagnosed with chronic obstructive pulmonary disease (COPD). The CDC noted in 2014 that this disease was the third leading cause of death in the U.S. Previous research has estimated that between
Indianapolis, Ind. (April 10, 2018) -- Donna Sparks combats a progressive life-threatening lung disease with courage, conviction and compassion -- for herself and others who share her fight. Diagnosed three years ago with pulmonary hypertension (PH), Donna is an active participant in myPHA, the Pulmonary Hypertension Association (PHA)’s online support community for individuals and
Andrew Sweatt, M.D., Stanford University, and Nadine Al-Naamani, M.D., M.S., University of Pennsylvania, are the research awardees of the 2017 PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension and Aldrighetti Research Award for Young Investigators, respectively. In the first of a two-part series, Dr. Sweatt discusses his research journey, grant awarded study and involvement with the
Note: PHA cautions PH patients to check with their doctor before taking up yoga, meditation and other mindfulness practices. Pulmonary hypertension (PH) is a progressive disease that affects the heart and the lungs (Lai, Potoka, Champion, Mora & Gladwin, 2014). Patients with this disease are treated to help control the pulmonary pressures and prevent
The Pulmonary Hypertension Association (PHA) launched a survey of the pediatric PH community today to learn more about the needs of children with PH, their parents and providers. This brief survey closes on Friday, April 20, and should be taken by any member of the pediatric PH community. In 2016, PHA conducted a community-wide survey
Silver Spring, Md. (March 28, 2018) - At Manasquan High School in Manasquan, NJ, where she taught physical education and health classes for 35 years, Sharyn Robbins was a role model for healthy, fit living. On top of teaching PE and Health classes, she coached girls’ field hockey, basketball, bowling and softball. During her
